Consultation Deadline Approaches For New Industry Fees In Ireland
Increased responsibilities and planned increases in staff numbers are among the reasons behind the Irish Health Products Regulatory Authority’s proposals to increase its fees next year.
You may also be interested in...
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.
New medicines under evaluation at the European Medicines Agency.
The European Medicine Agency has recommended extending the therapeutic indication of a raft of drugs that are already authorized in the EU.